Endovia Health Sciences enters letter agreement with C/M Capital Master Fund

EDVA•2026-10-15

Endovia Health Sciences entered a letter agreement with C/M Capital Master Fund on Oct. 15, 2026, increasing the beneficial ownership limitation to 9.99% effective immediately and waiving notice requirements and inconsistent provisions in a purchase agreement.

1. Agreement terms

Endovia Health Sciences entered a letter agreement with C/M Capital Master Fund on Oct. 15, 2026. The company increased the beneficial ownership limitation to 9.99% effective immediately and waived notice requirements and provisions inconsistent with a purchase agreement.

Endovia Health Sciences enters letter agreement with C/M Capital Master Fund

1. Agreement terms

Related News

Global stocks flat as AI and rate fears hit tech

Fermi 10% owner Toby R. Neugebauer reports $14.36 million share disposal

Nasdaq trade halt continues; reason not available at 5:46 p.m.

Avnet amends credit agreement, increasing commitments by $1 billion to $2.75 billion

CCC Intelligent Solutions agrees to $6.1 billion take-private deal with GTCR, Elliott